Bonalive advances the world’s transition to sustainable solutions for infection treatment and bone regeneration. We envision a world where diabetic foot osteomyelitis can be treated without local antibiotics – a smarter world, for a smarter life.
Diabetes and, in particular, diabetic foot osteomyelitis (DFO) is a rapidly increasing disease. Together with antimicrobial resistance (AMR) it is one of the greatest challenges facing healthcare today. We provide Smart Healing™, which means we focus on solutions that facilitate conservative surgery in the treatment of DFO. Smart Healing™ restores body function through the patient’s own biological processes without the need for local antibiotics.
The long-term clinical use of our Bonalive® products has proven to be safe and effective in osteomyelitis surgery. The world needs solutions that are smarter and more sustainable for all patients worldwide.
For bone regeneration in the diabetic foot with chronic osteomyelitis, we offer Bonalive® granules. For facilitation of granule containment in challenging diabetic foot surgery, Bonalive® putty can be used.